Literature DB >> 29528389

Dose-Dependent Negative Effects of Prior Multiple Vaccinations Against Influenza A and Influenza B Among Schoolchildren: A Study of Kamigoto Island in Japan During the 2011-2012, 2012-2013, and 2013-2014 Influenza Seasons.

Nobuo Saito1,2, Kazuhiro Komori3, Motoi Suzuki1,2, Takayuki Kishikawa3, Takahiro Yasaka3, Koya Ariyoshi1,2.   

Abstract

Background: We investigated the negative effects of prior multiple vaccinations on influenza vaccine effectiveness (VE) and analyzed the association of VE with prior vaccine doses.
Methods: Patients aged 9-18 years presenting with influenza-like illness at a community hospital on a remote Japanese island during the 2011-2012, 2012-2013, and 2013-2014 influenza seasons were tested for influenza using a rapid diagnostic test (RDT). A test-negative, case-control study design was used to estimate the VEs of trivalent inactivated influenza vaccine. Histories of vaccination and medically attended influenza (MA-flu) A and B during 3 previous seasons were collected from registry systems. VE was calculated using multilevel mixed-effects logistic regression models adjusted for the history of RDT-confirmed MA-flu.
Results: During 3 influenza seasons, 1668 influenza-like illness episodes were analyzed, including 421 and 358 episodes of MA-fluA and MA-fluB, respectively. The adjusted VE (95% confidence interval) yielded significant dose-dependent attenuations by prior vaccinations against both MA-fluA (0 doses during previous 3 seasons: 96% [69%-100%], 1 dose: 48% [-7% to 74%], 2 doses: 52% [11%-74%], 3 doses: 21% [-25% to 51%]; P for trend < .05) and MA-fluB (0 doses: 66% [-5% to 89%], 1 dose: 48% [-14% to 76%], 2 doses: 34% [-33% to 67%], 3 doses: -7% [-83% to 37%]; P for trend < .05). After excluding episodes of MA-flu during prior 3 seasons, similar trends were observed. Conclusions: Repeated previous vaccinations over multiple seasons had significant dose-dependent negative impacts on VE against both MA-fluA and MA-fluB. Further studies to confirm this finding are necessary.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29528389     DOI: 10.1093/cid/ciy202

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

2.  Earliest infections predict the age distribution of seasonal influenza A cases.

Authors:  Philip Arevalo; Huong Q McLean; Edward A Belongia; Sarah Cobey
Journal:  Elife       Date:  2020-07-07       Impact factor: 8.140

Review 3.  Immune History and Influenza Vaccine Effectiveness.

Authors:  Joseph A Lewnard; Sarah Cobey
Journal:  Vaccines (Basel)       Date:  2018-05-21

4.  Molecular evolution of influenza B virus during 2011-2017 in Chaoyang, Beijing, suggesting the free influenza vaccine policy.

Authors:  Na Lei; Hai-Bin Wang; Yu-Song Zhang; Jian-Hong Zhao; Yi Zhong; Yuan-Jie Wang; Li-Yong Huang; Jian-Xin Ma; Qiang Sun; Lei Yang; Yue-Long Shu; Shu-Ming Li; Ling-Li Sun
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

Review 5.  Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.

Authors:  Ronald N Kostoff; Darja Kanduc; Alan L Porter; Yehuda Shoenfeld; Daniela Calina; Michael B Briggs; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Toxicol Rep       Date:  2020-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.